These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 5082245)

  • 21. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 22. [Importance of the continuity of anti-hypertension treatment in prevention of ischemic cardiovascular diseases: preliminary note. Controlled study of hypertensive patients treated with amiloride associated with hydrochlorothiazide and chlorthalidone].
    de Pasquale C; Currò F; Amadeo A
    Minerva Med; 1978 Jun; 69(31):2115-23. PubMed ID: 351464
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of amiloride hydrochloride (MK-870) in patients with cirrhosis.
    Grayer D; Iber F
    Johns Hopkins Med J; 1969 Aug; 125(2):78-83. PubMed ID: 5347782
    [No Abstract]   [Full Text] [Related]  

  • 25. [Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
    Bianchi Porre G; Lazzaroni M; Petrillo M
    Nouv Presse Med; 1975 Apr; 4(14):1043. PubMed ID: 1093119
    [No Abstract]   [Full Text] [Related]  

  • 26. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Properties and indications of potassium-sparing diuretics].
    Rorive G; Krzesinski JM
    Rev Med Liege; 1986 May; 41(9):330-6. PubMed ID: 3523669
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term treatment of hypertension with the combination of hydrochlorothiazine and amiloride. Results of a multi-center study of 277 patients].
    Buscarini L; Camarri E; Camerini F; Scardi S; Alberti E; Fontana G; Forattini C; Alessi A; Perin S; Furlanello F; Vergara G; Del Favero A; Lechi A; Lenzi S; Bernardi P; Pecoraro F; Baraldini L; Bastagli L; Malamani V; Bellomo G; Migone L; Dal Canton A; Nava S; Antognetti R; Passeri M; Pallumeri E; Piccolo E; De Piccoli B; Cazzin R; Scarpioni L; Giorgi-Pierfranceschi D
    Minerva Cardioangiol; 1978 Nov; 26(11):705-12. PubMed ID: 724116
    [No Abstract]   [Full Text] [Related]  

  • 29. [The combination of hydrochlorothiazide, amiloride and alpha-methyldopa in the treatment of arterial hypertension. Clinical evaluation of a multicentric study].
    Masacci E; Montemartini C; Bobba P; Croce L; Ricciardi S; Mussari A; Bernardi P; Dalla Torre M; Di Benedetto A; Santucci F; Lombardo M; Galassi A
    Minerva Cardioangiol; 1979 Dec; 27(12):801-6. PubMed ID: 550094
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use and abuse of potassium-saving diuretics].
    Berg KJ
    Tidsskr Nor Laegeforen; 1979 Mar; 99(8):436-7. PubMed ID: 432873
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diuretic therapy in the aged. A clinical comparison between two diuretic compounds].
    Della Marchina MM; Renzi G; Serofilli S
    Minerva Med; 1981 Jan; 72(3):163-6. PubMed ID: 7207841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiopathological basis for a tailored management of essential hypertension].
    Albertazzi A; Del Rosso G; Di Paolo B; Spisni C; Palmieri PF; Cappelli P; Di Vito R
    Clin Ter; 1981 Feb; 96(4):359-69. PubMed ID: 6111413
    [No Abstract]   [Full Text] [Related]  

  • 33. [Esmaloride--a new potassium neutral diuretic combination. Clinical pharmacologic properties].
    Pabst J; Leopold G; Ungethüm W; Simane Z; Bühring KU
    Fortschr Med; 1985 Feb; 103(6):125-9. PubMed ID: 3988214
    [No Abstract]   [Full Text] [Related]  

  • 34. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
    Haris A; Radó J
    Orv Hetil; 1996 Sep; 137(35):1907-14. PubMed ID: 8927344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of diuretic-induced electrolyte disturbances by amiloride in patients with ascites due to cirrhosis of the liver.
    Bianchi Porro G; Petrillo M
    Acta Cardiol; 1973; ():Suppl 17:307-1. PubMed ID: 4543703
    [No Abstract]   [Full Text] [Related]  

  • 37. Significance of hypokalaemia due to diuretics.
    Leemhuis MP; Struyvenberg A
    Neth J Med; 1973; 16(1):18-28. PubMed ID: 4572424
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of cardiac failure with diuretics. A double-blind study comparing a fixed combination of hydrochlorothiazide/amiloride and furosemide plus potassium substitution].
    Kremer D
    Tidsskr Nor Laegeforen; 1983 May; 103(14):1165-8. PubMed ID: 6349006
    [No Abstract]   [Full Text] [Related]  

  • 39. Selected mechanisms of diuretic-induced electrolyte changes.
    Melby JC
    Am J Cardiol; 1986 Jul; 58(2):1A-4A. PubMed ID: 3524183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of a field study with Moducrin in 12596 hypertensive patients].
    Bergis K
    Med Welt; 1979 Nov; 30(46):1733-7. PubMed ID: 537497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.